279 filings
Page 9 of 14
4
9kyyoxzp
14 Feb 19
Deciphera Pharmaceuticals / Michael Douglas Taylor ownership change
12:00am
SC 13G
w4b1cre5oflul4 1wf
13 Feb 19
Deciphera Pharmaceuticals, Inc.
12:00am
4
moarq1avsv4v2ivfahso
7 Feb 19
Deciphera Pharmaceuticals / James Arthur Bristol ownership change
4:09pm
4
issg3i9w 5oyjqg2otf
7 Feb 19
Deciphera Pharmaceuticals / Michael Douglas Taylor ownership change
4:04pm
4
2dwhooq4dp
1 Feb 19
Deciphera Pharmaceuticals / Michael Douglas Taylor ownership change
4:21pm
4
qsytnfq6ik 4ac4ter5
1 Feb 19
Deciphera Pharmaceuticals / Stephen B. Ruddy ownership change
4:19pm
4
pq7deg
1 Feb 19
Deciphera Pharmaceuticals / Christopher John Morl ownership change
4:18pm
4
qjtymd6c6 p4gj
1 Feb 19
Deciphera Pharmaceuticals / Daniel C. Martin ownership change
4:17pm
4
sc3cu3 yud0u
1 Feb 19
Deciphera Pharmaceuticals / Thomas Patrick Kelly ownership change
4:14pm
4
swh84hv02 8wxp
1 Feb 19
Deciphera Pharmaceuticals / Daniel Lee Flynn ownership change
4:13pm
4
anykh9f
18 Jan 19
Deciphera Pharmaceuticals / Daniel Lee Flynn ownership change
4:13pm
4
7496clbh ck0
15 Jan 19
Deciphera Pharmaceuticals / Daniel Lee Flynn ownership change
5:00pm
SC 13G/A
3q7qm i6we5scjfijxs
10 Jan 19
Deciphera Pharmaceuticals, Inc.
8:10pm
4
er3uw
9 Jan 19
Deciphera Pharmaceuticals / Thomas Patrick Kelly ownership change
4:54pm
SC 13D/A
51uyh
2 Jan 19
Deciphera Pharmaceuticals, Inc.
4:05pm
8-K
9c9rjh
8 Nov 18
Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results
7:10am
8-K
dv6b s1xqh
19 Oct 18
Ongoing Phase 1 Trial Update
4:13pm
EFFECT
gchn7x0lpt ftk
15 Oct 18
Notice of effectiveness
12:15am
UPLOAD
8db5g3
10 Oct 18
Letter from SEC
12:00am